Food groups and colorectal cancer risk
- 作者Levi, F; Pasche, C; La Vecchia, C; Lucchini, F; Franceschi, S
- 卷第79卷
- 期第7期
- 印刷ISSN0007-0920
- 电子ISSN1532-1827
- 文件大小82.38KB
- 发表时间1999
- DOI10.1038/sj.bjc.6690206
- 页码1283-1287
BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric PopulationPerez-Huertas, P.; Cueto-Sola, M.; Escobar-Cava, P.; Fernandez-Navarro, J. M.; Borrell-Garcia, C.; Albert-Mari, A.; Lopez-Briz, E.; Poveda-Andres, J. L. · Journal of Pediatric Oncology Nursing · 2016
1562PDMagnitude of clinical benefit of cancer drugs approved based on single-arm trials (SAT) by the US Food and Drug Administration (FDA)Molto Valiente, C; Borrell, M; Ocana Fernandez, A; Templeton, A J; del Carpio, L P; Del Paggio, J; Barnadas, A; Booth, C M; Tibau, A; Amir, E · Annals of Oncology · 2018
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical PracticeChamorro-de-Vega, E.; Gimenez-Manzorro, A.; Rodriguez-Gonzalez, C. G.; Escudero-Vilaplana, V.; Collado Borrell, R.; Ibanez-Garcia, S.; Lallana Sainz, E.; Lobato Matilla, E.; Lorenzo-Pinto, A.; Manrique-Rodriguez, S.; Fernandez-Llamazares, C. M.; Marzal-Alfaro, M.; Ribed, A.; Romero Jimenez, R. M.; Sarobe Gonzalez, C.; Herranz, A.; Sanjurjo, M. · Annals of Pharmacotherapy · 2016
A multi-center study of epidemiological cutoff values and detection of resistance in <i>Candida</i> spp. to anidulafungin, caspofungin and micafungin using the Sensititre® YeastOne colorimetric methodEspinel-Ingroff, A.; Alvarez-Fernandez, M.; Cantón, E.; Carver, P. L.; Chen, S. C-A.; Eschenauer, G.; Getsinger, D. L.; Gonzalez, G. M.; Govender, N. P.; Grancini, A.; Hanson, K. E.; Kidd, S. E.; Klinker, K.; Kubin, C. J.; Kus, J.V.; Lockhart, S. R.; Meletiadis, J.; Morris, A. J.; Pelaez, T.; Quindós, G.; Rodriguez-Iglesias, M.; Sánchez-Reus, F.; Shoham, S.; Wengenack, N. L.; Borrell Solé, N.; Echeverria, J.; Esperalba, J.; Gómez-G. de la Pedrosa, E.; García García, I.; Linares, M. J.; Marco, F.; Merino, P.; Pemán, J.; Pérez del Molino, L.; Roselló Mayans, E.; Rubio Calvo, C.; Ruiz Pérez de Pipaon, M.; Yagüe, G.; Garcia-Effron, G.; Guinea, J.; Perlin, D. S.; Sanguinetti, M.; Shields, R.; Turnidge, J. · Antimicrobial Agents and Chemotherapy · 2015
Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratoriesAlvarado-Cardenas, M.; Marin-Sánchez, A.; Martínez, M.A.; Martínez-Martínez, L.; Pinal-Fernandez, I.; Labrador-Horrillo, M.; Balada, E.; Mundet-Tuduri, X.; Gonzalez-Mera, L.; Casademont, J.; Acebes, E. Martínez; Moreno, P.J.; Juarez, C.; Grau-Junyent, J.M.; Pujol-Borrell, R.; Selva-O'Callaghan, A. · Autoimmunity Reviews · 2016
1563PDMagnitude of clinical benefit in trials supporting US Food and Drug Administration (FDA) accelerated approval (AA) and European Medicines Agency (EMA) conditional marketing authorisation (CMA) and subsequent trials supporting conversion to full approvalBorrell Puy, M; Molto Valiente, C; Vokinger, K; Hwang, T; Ocana Fernandez, A; Templeton, A J; Seruga, B; Gich Saladich, I; Barnadas, A; Amir, E; Tibau, A · Annals of Oncology · 2018